Question 1

What is STERIS's P/B ratio?

Accepted Answer

STERIS (STE) P/B ratio is 2.9× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by book value of equity, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/B ratio calculated?

Accepted Answer

P/B = Market Capitalisation ÷ Book Value of Equity (most recent quarterly shareholders' equity), or equivalently Share Price ÷ Book Value Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/B ratio?

Accepted Answer

The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.

Question 4

What is a good P/B ratio for STERIS?

Accepted Answer

A "good" P/B depends on the business model. Banks, insurers, and other capital-heavy financials typically trade near 1×; asset-light technology and consumer-brand companies can sustainably trade at 5×+ because much of their value is intangible. P/B is most informative when paired with return on equity (ROE). For STERIS specifically, the relevant sector benchmark is the current sector median of 3.4×.

Question 5

Is STERIS's P/B ratio high or low?

Accepted Answer

STERIS's P/B ratio of 2.9× is below its own 5-year average of 3.3× and below the sector median of 3.4×. That places the current reading at the 4th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is STERIS's historical P/B ratio range?

Accepted Answer

In the available daily series, STERIS (STE) P/B ratio has ranged from a low of 1.9× in 2009 to a high of 4.9× in 2021. The 5-year average is 3.3× and the 5-year median is 3.4×.

Question 7

What was STERIS's P/B ratio in 2026?

Accepted Answer

STERIS (STE) P/B ratio at the end of 2026 was 3.0×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month book value figure available at that date.

Question 8

Why does STERIS's P/B ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (book value). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2026	$21.67B	$7.18B	3.0×	-0.4×	Mar 31, 2026
2025	$22.27B	$6.60B	3.4×	-0.1×	Mar 31, 2025
2024	$21.85B	$6.30B	3.5×	+0.3×	Mar 31, 2024
2023	$18.95B	$6.08B	3.1×	-0.6×	Mar 31, 2023
2022	$24.20B	$6.53B	3.7×	-0.5×	Mar 31, 2022
2021	$16.26B	$3.88B	4.2×	+0.7×	Mar 31, 2021
2020	$11.88B	$3.41B	3.5×	+0.1×	Mar 31, 2020
2019	$10.77B	$3.18B	3.4×	+0.9×	Mar 31, 2019
2018	$7.92B	$3.21B	2.5×	+0.4×	Mar 31, 2018
2017	$5.90B	$2.80B	2.1×	+0.1×	Mar 31, 2017
2016	$6.10B	$3.02B	2.0×	-1.9×	Mar 31, 2016
2015	$4.19B	$1.07B	3.9×	+1.2×	Mar 31, 2015
2014	$2.81B	$1.04B	2.7×	+0.2×	Mar 31, 2014
2013	$2.41B	$944.94M	2.6×	+0.3×	Mar 31, 2013
2012	$1.82B	$821.40M	2.2×	-0.4×	Mar 31, 2012
2011	$2.05B	$787.57M	2.6×	-0.0×	Mar 31, 2011
2010	$1.98B	$753.71M	2.6×	+0.7×	Mar 31, 2010
2009	$1.36B	$717.74M	1.9×	-0.4×	Mar 31, 2009
2008	$1.65B	$706.15M	2.3×	+0.1×	Mar 31, 2008
2007	$1.71B	$774.29M	2.2×	-0.0×	Mar 31, 2007
2006	$1.65B	$730.83M	2.3×	-0.1×	Mar 31, 2006
2005	$1.76B	$755.64M	2.3×	-0.3×	Mar 31, 2005
2004	$1.77B	$680.70M	2.6×	-0.6×	Mar 31, 2004
2003	$1.81B	$569.53M	3.2×	+0.2×	Mar 31, 2003
2002	$1.46B	$487.14M	3.0×	—	Mar 31, 2002


Quest Diagnostics (DGX)	2.9×
Moderna (MRNA)	2.7×
Charles River (CRL)	2.6×
Regeneron Pharmaceuticals (REGN)	2.6×
Henry Schein (HSIC)	2.5×
Labcorp Holdings (LH)	2.5×
Danaher (DHR)	2.4×
UnitedHealth Group (UNH)	2.4×
Solventum (SOLV)	2.3×
Becton, Dickinson and (BDX)	1.8×
Pfizer (PFE)	1.8×
Molina Healthcare (MOH)	1.7×
Cigna (CI)	1.7×
Waters Corporation (WAT)	1.6×
Cooper Companies (COO)	1.5×
Elevance Health (ELV)	1.5×
Universal Health Services (UHS)	1.5×
Biogen (BIIB)	1.4×
Baxter International (BAX)	1.4×
Revvity (RVTY)	1.4×
Zimmer Biomet Holdings (ZBH)	1.2×
CVS Health (CVS)	1.2×
Humana (HUM)	1.1×
Viatris (VTRS)	1.1×
Centene (CNC)	0.8×

P/B Ratio for STERIS (STE)

P/B Ratio daily chart for STERIS (STE)

Historical P/B Ratio for STERIS (STE) from 2002 to 2026

About P/B Ratio at STERIS (STE)

STERIS P/B Ratio by Year

STERIS P/B Ratio 2026: 3.0×

STERIS P/B Ratio 2025: 3.4×

STERIS P/B Ratio 2024: 3.5×

STERIS P/B Ratio 2023: 3.1×

STERIS P/B Ratio 2022: 3.7×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

STERIS (STE) Key Financials

P/B Ratio daily chart for STERIS (STE)

Historical P/B Ratio for STERIS (STE) from 2002 to 2026

About P/B Ratio at STERIS (STE)

STERIS P/B Ratio by Year

STERIS P/B Ratio 2026: 3.0×

STERIS P/B Ratio 2025: 3.4×

STERIS P/B Ratio 2024: 3.5×

STERIS P/B Ratio 2023: 3.1×

STERIS P/B Ratio 2022: 3.7×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

+What is STERIS's P/B ratio?

+How is the P/B ratio calculated?

+What is the P/B ratio?

+What is a good P/B ratio for STERIS?

+Is STERIS's P/B ratio high or low?

+What is STERIS's historical P/B ratio range?

+What was STERIS's P/B ratio in 2026?

+Why does STERIS's P/B ratio change over time?

STERIS (STE) Key Financials